Making cancer treatment faster and cheaper: The EU-funded research project MIRACLE is developing a small, low-cost, fully automated technical device that isolates and analyses circulating tumour cells from peripheral blood.

Cancer remains a prominent health concern affecting modern societies. Continuous innovations and introduction of new technologies are essential to level or even reduce current healthcare spending.
The research project MIRACLE aims to develop a low-cost, fully automated, integrated lab-on-a-chip (LOC) system for the isolation, counting and characterization of occult tumour cells starting directly from clinical samples.
MIRACLE is a collaborative project between 14 partners from universities, research institutions and companies from all over Europe.

The project is funded by the European Commission within the 7th Framework Programme. It has started in 2010, and should finish in 2014.